Literature DB >> 24313747

Underscoring the influence of inorganic chemistry on nuclear imaging with radiometals.

Brian M Zeglis1, Jacob L Houghton, Michael J Evans, Nerissa Viola-Villegas, Jason S Lewis.   

Abstract

Over the past several decades, radionuclides have matured from largely esoteric and experimental technologies to indispensible components of medical diagnostics. Driving this transition, in part, have been mutually necessary advances in biomedical engineering, nuclear medicine, and cancer biology. Somewhat unsung has been the seminal role of inorganic chemistry in fostering the development of new radiotracers. In this regard, the purpose of this Forum Article is to more visibly highlight the significant contributions of inorganic chemistry to nuclear imaging by detailing the development of five metal-based imaging agents: (64)Cu-ATSM, (68)Ga-DOTATOC, (89)Zr-transferrin, (99m)Tc-sestamibi, and (99m)Tc-colloids. In a concluding section, several unmet needs both in and out of the laboratory will be discussed to stimulate conversation between inorganic chemists and the imaging community.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24313747      PMCID: PMC4151561          DOI: 10.1021/ic401607z

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  230 in total

Review 1.  Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy.

Authors:  James L Tatum; Gary J Kelloff; Robert J Gillies; Jeffrey M Arbeit; J Martin Brown; K S Clifford Chao; J Donald Chapman; William C Eckelman; Anthony W Fyles; Amato J Giaccia; Richard P Hill; Cameron J Koch; Murali Cherukuri Krishna; Kenneth A Krohn; Jason S Lewis; Ralph P Mason; Giovanni Melillo; Anwar R Padhani; Garth Powis; Joseph G Rajendran; Richard Reba; Simon P Robinson; Gregg L Semenza; Harold M Swartz; Peter Vaupel; David Yang; Barbara Croft; John Hoffman; Guoying Liu; Helen Stone; Daniel Sullivan
Journal:  Int J Radiat Biol       Date:  2006-10       Impact factor: 2.694

Review 2.  Towards new transition metal-based hypoxic selective agents for therapy and imaging.

Authors:  P J Blower; J R Dilworth; R I Maurer; G D Mullen; C A Reynolds; Y Zheng
Journal:  J Inorg Biochem       Date:  2001-05       Impact factor: 4.155

3.  Efficient bifunctional gallium-68 chelators for positron emission tomography: tris(hydroxypyridinone) ligands.

Authors:  David J Berry; Yongmin Ma; James R Ballinger; Richard Tavaré; Alexander Koers; Kavitha Sunassee; Tao Zhou; Saima Nawaz; Gregory E D Mullen; Robert C Hider; Philip J Blower
Journal:  Chem Commun (Camb)       Date:  2011-05-27       Impact factor: 6.222

4.  ImmunoSPECT and immunoPET of IGF-1R expression with the radiolabeled antibody R1507 in a triple-negative breast cancer model.

Authors:  Sandra Heskamp; Hanneke W M van Laarhoven; Janneke D M Molkenboer-Kuenen; Gerben M Franssen; Yvonne M H Versleijen-Jonkers; Wim J G Oyen; Winette T A van der Graaf; Otto C Boerman
Journal:  J Nucl Med       Date:  2010-09-16       Impact factor: 10.057

5.  H4octapa: an acyclic chelator for 111In radiopharmaceuticals.

Authors:  Eric W Price; Jacqueline F Cawthray; Gwendolyn A Bailey; Cara L Ferreira; Eszter Boros; Michael J Adam; Chris Orvig
Journal:  J Am Chem Soc       Date:  2012-05-11       Impact factor: 15.419

6.  Preparation and evaluation of (68)Ga-DOTA-hEGF for visualization of EGFR expression in malignant tumors.

Authors:  Irina Velikyan; Asa Liljegren Sundberg; Orjan Lindhe; A Urban Höglund; Olof Eriksson; Eva Werner; Jorgen Carlsson; Mats Bergström; Bengt Långström; Vladimir Tolmachev
Journal:  J Nucl Med       Date:  2005-11       Impact factor: 10.057

Review 7.  New directions in the coordination chemistry of 99mTc: a reflection on technetium core structures and a strategy for new chelate design.

Authors:  Sangeeta Ray Banerjee; Kevin P Maresca; Lynn Francesconi; John Valliant; John W Babich; Jon Zubieta
Journal:  Nucl Med Biol       Date:  2005-01       Impact factor: 2.408

8.  89Zr-DFO-J591 for immunoPET of prostate-specific membrane antigen expression in vivo.

Authors:  Jason P Holland; Vadim Divilov; Neil H Bander; Peter M Smith-Jones; Steven M Larson; Jason S Lewis
Journal:  J Nucl Med       Date:  2010-07-21       Impact factor: 10.057

Review 9.  Assessing tumor hypoxia by positron emission tomography with Cu-ATSM.

Authors:  J P Holland; J S Lewis; F Dehdashti
Journal:  Q J Nucl Med Mol Imaging       Date:  2009-04       Impact factor: 2.346

10.  Perfusion and function at rest and treadmill exercise using technetium-99m-sestamibi: comparison of one- and two-day protocols in normal volunteers.

Authors:  S Borges-Neto; R E Coleman; R H Jones
Journal:  J Nucl Med       Date:  1990-07       Impact factor: 10.057

View more
  26 in total

Review 1.  A brief overview of metal complexes as nuclear imaging agents.

Authors:  Douglas S MacPherson; Kimberly Fung; Brendon E Cook; Lynn C Francesconi; Brian M Zeglis
Journal:  Dalton Trans       Date:  2019-10-07       Impact factor: 4.390

2.  Recent applications of a single quadrupole mass spectrometer in 11C, 18F and radiometal chemistry.

Authors:  Thomas L Collier; Kenneth Dahl; Nickeisha A Stephenson; Jason P Holland; Adam Riley; Steven H Liang; Neil Vasdev
Journal:  J Fluor Chem       Date:  2018-03-05       Impact factor: 2.050

3.  Theranostic Targeting of CUB Domain Containing Protein 1 (CDCP1) in Pancreatic Cancer.

Authors:  Anna Moroz; Yung-Hua Wang; Jeremy M Sharib; Junnian Wei; Ning Zhao; Yangjie Huang; Zhuo Chen; Alexander J Martinko; Jie Zhuo; Shion A Lim; Lydia H Zhang; Youngho Seo; Sean Carlin; Kevin K Leung; Eric A Collisson; Kimberly S Kirkwood; James A Wells; Michael J Evans
Journal:  Clin Cancer Res       Date:  2020-04-27       Impact factor: 12.531

Review 4.  Evaluation of hypoxia with copper-labeled diacetyl-bis(N-methylthiosemicarbazone).

Authors:  Suzanne E Lapi; Jason S Lewis; Farrokh Dehdashti
Journal:  Semin Nucl Med       Date:  2015-03       Impact factor: 4.446

5.  Stable Radiolabeling of Sulfur-Functionalized Silica Nanoparticles with Copper-64.

Authors:  Travis M Shaffer; Stefan Harmsen; Emaad Khwaja; Moritz F Kircher; Charles Michael Drain; Jan Grimm
Journal:  Nano Lett       Date:  2016-08-01       Impact factor: 11.189

Review 6.  Preclinical optimization of antibody-based radiopharmaceuticals for cancer imaging and radionuclide therapy-Model, vector, and radionuclide selection.

Authors:  Lukas M Carter; Sophie Poty; Sai Kiran Sharma; Jason S Lewis
Journal:  J Labelled Comp Radiopharm       Date:  2018-03-30       Impact factor: 1.921

Review 7.  Nanoparticles and radiotracers: advances toward radionanomedicine.

Authors:  Edwin C Pratt; Travis M Shaffer; Jan Grimm
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-03-23

Review 8.  Targeted α-therapy of prostate cancer using radiolabeled PSMA inhibitors: a game changer in nuclear medicine.

Authors:  Rubel Chakravarty; Cerise M Siamof; Ashutosh Dash; Weibo Cai
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-08-20

Review 9.  89 Zr-ImmunoPET companion diagnostics and their impact in clinical drug development.

Authors:  Brooke N McKnight; Nerissa T Viola-Villegas
Journal:  J Labelled Comp Radiopharm       Date:  2018-03-12       Impact factor: 1.921

10.  Inverse electron demand Diels-Alder click chemistry for pretargeted PET imaging and radioimmunotherapy.

Authors:  Samantha M Sarrett; Outi Keinänen; Eric J Dayts; Guillaume Dewaele-Le Roi; Cindy Rodriguez; Kathryn E Carnazza; Brian M Zeglis
Journal:  Nat Protoc       Date:  2021-06-14       Impact factor: 13.491

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.